Pelvic floor muscle exercise for fecal incontinence quality of life after coloanal anastomosis

Abstract

Early education in pelvic floor muscle exercise can improve management of fecal incontinence symptoms after coloanal anastomosis and can improve quality of life.

Systematic Review of Functional Outcomes in Cancer Rehabilitation

“…These studies were conducted across breast (n=39), gynecologic 39-43 (n=5), colon and GI [44][45][46][47][48][49][50] (n=7), hematologic [51][52][53] (n=3), head and neck 54,55 (n=2), lung 56,57 (n=2), prostate 58,59 (n=2), and brain and CNS 60 (n=1) cancers, while 19 studies included various cancer diagnoses in their cohort [61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79] . A variety of cancer stages were represented across the studies, yet 34 studies did not specify stage of cancer for their cohort.…”

The Effect of Pelvic Floor Rehabilitation on Lower Anterior Resection Syndrome After Colorectal Cancer Treatment

“…Evaluation of LARS, its effect on QOL, and potential treatment strategies within the rst 12 months from surgery should be emphasized to improve functional outcomes and QOL and lessen patient anxiety related to bowel changes. This builds on previous studies reporting gainful bene t in bowel function and QOL when therapy is introduced within 12 months of surgery [3,9,14].…”

“…This constellation of symptoms has been named lower anterior resection syndrome (LARS). Incidence of LARS in the U.S. ranges from 19-90% [1,[3][4][5][6][7][8][9][10]. Daily bowel Bowel dysfunction following LAR can develop immediately or later; there is no absolute association between time from treatment and development of LARS.…”

“…Daily bowel Bowel dysfunction following LAR can develop immediately or later; there is no absolute association between time from treatment and development of LARS. [2,3]. There are ample studies evaluating LARS 1 year or more after treatment, but few evaluating it within the rst year.…”

“…There are ample studies evaluating LARS 1 year or more after treatment, but few evaluating it within the rst year. At project inception, only three studies assessed PFR for LARS and QOL measures within the rst year from surgery [3,9,14]. Evaluation of LARS, its effect on QOL, and potential treatment strategies within the rst 12 months from surgery should be emphasized to improve functional outcomes and QOL and lessen patient anxiety related to bowel changes.…”